ÐÏࡱá>þÿ 57þÿÿÿ4ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥Á€ ð¿Cbjbj´V´V 4Ö<Ö<C ÿÿÿÿÿÿ·Ø Ø ÿÿÿÿ//// ;/Ò >WWWWW222u w w w w w w #¢²%Bw 22222w WWÛŒ ÆÆÆ2^WWu Æ2u ÆÆ:y,ÝWÿÿÿÿª—m¡mÌ/�¥ a ¢ 0Ò ¯.ô%¦ô%Ýô%Ý„22Æ22222w w ¶222Ò 2222ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿô%222222222Ø á: DRUG DEVELOPMENT (MSc/PgDip with a view to transfer to MSc/PgDip/PgCert) 57B2DDB1/61B2DDB1/61B2DDVX/62B2DDVZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard in Pharmacology, Pharmacy or a relevant Science subject (e.g. Biochemistry, Biomedical Sciences, Biology). Duration: 12 months full-time or 24 months part-time (MSc); 9 months full-time or 18 months part-time (PgDip). Aim: To equip students for careers developing and expanding current knowledge of drug development. To achieve this the programme will provide a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug action; preclinical and clinical trials; and regulatory affairs. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and demonstrations in clinical departments. The curriculum includes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion; toxicology; pharmacokinetics; statistics; computing studies; industrial aspects of drug development; therapeutics; therapeutic drug monitoring; the influence of disease on drug handling; drug-drug interactions; the design and conduct of volunteer and clinical trials; monitoring drug safety. Candidates shall be required to attend the following designated programme of courses: Stage 1 GS 50M1 Generic Skills (0 credit points) MT 5003 Drug Metabolism and Toxicology (15 credit points) MT 5004 Therapeutics (10 credit points) MT 5006 Induction Course (5 credit points) MT 5014 Molecular Pharmacology, Drug Discovery and Development (20 credit points) PU 5005 Applied Statistics (10 credit points) SK 5003 Information Skills (0 credit points) Elective MB 5015 Molecular Biology Basics & Cloning Lab (15 credit points) Stage 2 MT 5501 Pharmacovigilance (5 credit points) MT 5502 Drug Development to Evidence Based Medicine (20 credit points) MT 5503 Pharmacokinetics (10 credit points) BT 5506 Business of Science (5 credit points) BT 5901 Laboratory Techniques – Core Practical Skills (10 credit points) MT 5506 “Omics” and Research (5 credit points) Elective MT 55EP Careers & Employability for Postgraduates (5 credit points) Diploma candidates may be allowed to transfer to the MSc if they complete the above programme at an appropriate standard. No candidate will be allowed to progress to Stage 3 as an MSc candidate if they fail to achieve an appropriate standard in the above programme. MSc candidates with a registered medical qualification may be able to carry out a clinical research project in the final stage under supervision of one of the medical staff. Stage 3 MSc only MT 5810 Research Project (65 credit points) PgDip only MT 5806 Dissertation in Drug Development (25 credit points) Assessment: By practical work, by written essays and by oral presentations, or by a combination of these, as prescribed for each course. The dissertation will be assessed and there may be an oral examination on completion of the programme. Candidates must pass all courses at an appropriate standard for the award of the MSc degree. noˆ7 @ ¨ ¬ Û ã W _ kst|©ª´òýBCóáÏÀÏÀÏÀÏÀ«À«À«¢áÀ¢áÀÏÀ› hå-ÚhïCJh °h °aJ)h °h °5�6�>*CJOJQJ^JaJh °h °OJQJ^JaJ"h °h °6�OJQJ]�^JaJ"h °h °5�OJQJ\�^JaJh °h °OJQJaJJno6 7 § ¨ Ú Û ÿ V W _ ` ‰ à ë h–ðÞÏÊÊÊÊÊÊÊÊÊÊÁʸ¸¸¸¸¸ Æ„gd °¤¤gd °gd ° Æ 06$dðgd °$ Æ 0D%dða$gd ° Æ 0D%dðgd °–ÃÄÍÎF�¹ç0`ajk¯°jkst}©ööööööéööööööööööööööéä×× „„„|ü^„„`„|ügd °gd °  Æ„¤¤gd ° Æ„gd °©ªµñòBCúíäääßgdå-Ú Æ„gd ° „„„|ü^„„`„|ügd °gd °21�h:p[=°‚. °ÆA!° "° #� $� %°°Ä°Ä �Äj ˜žžžžžžž666666666vvvvvvvvv66666>666666666666666666666666666¨6666666666¸6666666666hH66666666666666666666666666666666666666666666666666666666666666666°62ÀÐàð 0@P`p€�ÀÐàð2(Øè 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�8XøV~ OJPJQJ_HmH nH sH tH N`ñÿN ° Normal$a$ CJOJPJQJ_HmH sH tH `@` „+´� Heading 2$¤ð¤<@&$5�6�CJOJPJQJ\�]�^JaJ>@> °  Heading 3$d8ÿ@&5�XX î=� Heading 6 ¤ð¤<@&5�CJOJPJQJ\�^JaJRR "2^� Heading 7 ¤ð¤<@&CJOJPJQJ^JaJXX N$Ð� Heading 8 ¤ð¤<@&6�CJOJPJQJ]�^JaJDA òÿ¡D Default Paragraph FontRióÿ³R 0 Table Normalö4Ö l4Öaö (k ôÿÁ( 0No List Pþ¢ñP ° Heading 3 Char5CJOJPJQJ^JaJ\þ¢\ „+´�Heading 2 Char(56CJOJPJQJ\]^JaJtH 44 „+´Header  Æ9r Bþ¢!B „+´ Header CharCJOJPJQJtH Vþ¢1V î=�Heading 6 Char"5CJOJPJQJ\^JaJtH Pþ¢AP "2^�Heading 7 CharCJOJPJQJ^JaJtH JZRJ w�0 Plain Text$a$CJOJQJ^JtH Fþ¢aF w�0Plain Text CharOJPJQJ^JVQrV ft Body Text 3$ Æ0d6ÿa$ 5�OJQJPþ¢�P ftBody Text 3 Char5CJOJPJQJtH Vþ¢‘V N$Ð�Heading 8 Char"6CJOJPJQJ]^JaJtH 6U¢¡6 mOÛ Hyperlink >*B*phÿPK!‚мú[Content_Types].xml¬‘ËjÃ0E÷…þƒÐ¶Ørº(¥ØÎ¢Iw},Òä±-j�„4 Éßwì¸Pº-t#bΙ{U®�ã “óTéU^h…d}㨫ôûî)»×*1Pƒ'¬ô “^××Wåî0)™¦Též9<“l�#¤Ü$yi}�å;À~@‡æ¶(îŒõÄHœñÄÐuù* D× zƒÈ/0ŠÇ° ðûù $€˜ X«Ç3aZ¢ÒÂà,°D0j~è3ß¶Îbãí~i>ƒØÍ3¿\`õ?ê/ç[ج¶Géâ\Ä!ý-ÛRk.“sþÔ»�..—·´aæ¿­?ÿÿPK!¥Ö§çÀ6 _rels/.rels„�ÏjÃ0 ‡ï…½ƒÑ}QÒÃ%v/¥�C/£}á(h"ÛëÛOÇ »„¤ï÷©=þ®‹ùá”ç šªÃâC?Ëháv=¿‚É…¤§%[xp†£{Ûµ_¼PÑ£<Í1¥H¶0•ˆÙO¼R®BdÑÉÒJEÛ4b$§‘q_טžà6LÓõR×7`®�¨Éÿ³Ã0ÌžOÁ¯,åEn7”Liäb¡¨/ãS½�¨eªÔе¸ùÖýÿÿPK!ky–ƒŠtheme/theme/themeManager.xml ÌM à @á}¡w�Ù7c»(Eb²Ë®»öCœAÇ ÒŸÛ×åãƒ7ÎßÕ›K Y,œ ŠeÍ.ˆ·ð|,§¨ÚHÅ,láÇæéxÉ´�ßIÈsQ}#Õ�…­µÝ Öµ+Õ!ï,Ý^¹$j=‹GWèÓ÷)âEë+& 8ýÿÿPK!–µ­â–Ptheme/theme/theme1.xmlìYOoÛ6¿Øw toc'vuŠØ±›-MÄn‡i‰–ØP¢@ÒI}Úã€úa‡Øm‡a[�Ø¥û4Ù:lЯ°GR’ÅX^’6ØŠ­>$ùãûÿ©«×îÇ !)OÚ^ýrÍC$ñy@“°íÝö/­yH*œ˜ñ„´½)‘Þµ�÷ß»Š×UDb‚`}"×qÛ‹”J×—–¤ÃX^æ)I`nÌEŒ¼Šp)øèÆli¹V[]Š1M<”àÈÞ�©OÐP“ô6râ=¯‰’zÀgb Ig…Áu��SÙebÖö€OÀ�†ä¾òÃRÁDÛ«™Ÿ·´qu ¯g‹˜Z°¶´®o~ÙºlAp°lxŠpT0­÷­+[}`j×ëõº½zAϰV–2ÍF­ÞÉi–@öqžv·Ö¬5\|‰þʜ̭N§Óle²X¢dsøµÚjcsÙÁ�Å7çð�Îf·»êà ÈâWçðý+­Õ†‹7 ˆÑä`­ÚïgÔ È˜³íJøÀ×j|†‚h(¢K³óD-еß㢠dXÑ©iJÆØ‡(îâx$(Ö ð:Á¥;ä˹!Í I_ÐTµ½S 1£÷êù÷¯ž?EÇž?øéøáÃã?ZBΪmœ„åU/¿ýìÏÇ£?ž~óòÑÕxYÆÿúÃ'¿üüy5Òg&΋/ŸüöìÉ‹¯>ýý»GðM�Geø�ÆD¢›äíó3Vq%'#q¾ÃÓòŠÍ$”8ÁšKýžŠôÍ)f™w9:ĵàå£ x}rÏx‰‰¢œw¢ØîrÎ:\TZaGó*™y8IÂjæbRÆíc|XÅ»‹Ç¿½I u3KGñnD1÷NIBÒsü€� íîRêØu—ú‚K>Vè.EL+M2¤#'šf‹¶i ~™Vé þvl³{u8«Òz‹ºHÈ Ì*„æ˜ñ:ž(W‘☕ ~«¨JÈÁTøe\O*ðtHG½€HYµæ–}KNßÁP±*ݾ˦±‹ŠTѼ�9/#·øA7ÂqZ…Ð$*c?�¢íqUßån†èwðNºû%Ž»O¯·ièˆ4 =3Ú—Pª� ÓäïÊ1£P�m \\9†øâëÇ‘õ¶âMØ“ª2aûDù]„;Yt»\ôí¯¹[x’ìóù�ç]É}Wr½ÿ|É]”Ïg-´³Ú eW÷ ¶)6-r¼°CSÆjÊÈ išd ûDЇA½ÎœIqbJ#xÌ꺃 6k�àê#ª¢A„Sh°ëž&ÊŒt(QÊ%ìÌp%m�‡&]ÙcaSl=�XíòÀ¯èáü\P�1»MhŸ9£Mà¬ÌV®dDAí×aV×B�™[݈fJ�íP|8¯ Ö„AÛV^…ó¹f ÌH ín÷ÞÜ-Æ é"á€d>ÒzÏû¨nœ”ÇŠ¹ €Ø©ð‘>ä�bµ·–&ûÜÎâ¤2»Æv¹÷ÞÄKyϼ¤óöD:²¤œœ,AGm¯Õ\nzÈÇiÛÙã¼.uχYC¾6ìOMf“å3o¶rÅÜ$¨Ã5…µûœÂNH…T[XF64ÌT,Ñœ¬üËM0ëE)`#ý5¤XYƒ`ø×¤;º®%ã1ñUÙÙ¥m;ûš•R>QD ¢à�ØDìcp¿UÐ' ®&LEÐ/p�¦­m¦Üâœ%]ùöÊàì8fi„³r«S4Ïd 7y\È`ÞJâ�n•²åίŠIù R¥Æÿ3Uô~7+�ö€׸#�¯m� q¨BiDý¾€ÆÁÔˆ¸‹…i*¸L6ÿ9ÔÿmÎY&­áÀ§öiˆ…ýHE‚�=(K&úN!VÏö.K’e„LD•Ä•©{D 긪÷vEꦚdeÀàNÆŸûžeÐ(ÔMN9ßœRì½6þéÎÇ&3(åÖaÓÐäö/D¬ØUíz³<ß{ËŠè‰Y›Õȳ˜•¶‚V–ö¯)Â9·Z[±æ4^næÂ�ç5†Á¢!Já¾é?°ÿQá3ûeBo¨C¾µÁ‡M ¢ú’m<�.�vp�“´Á¤IYÓf­“¶Z¾Y_p§[ð=al-ÙYü}NcÍ™ËÎÉÅ‹4vfaÇÖvl¡©Á³'S†ÆùAÆ8Æ|Ò*uâ£{àè-¸ßŸ0%M0Á7%�¡õ˜<€ä·ÍÒ�¿ÿÿPK! Ñ�Ÿ¶'theme/theme/_rels/themeManager.xml.rels„�M Â0„÷‚wooÓº‘&݈ЭÔ„ä5 6?$Qìí ®,.‡a¾™i»—�Éc2Þ1hª:é•qšÁm¸ìŽ@RN‰Ù;d°`‚Žo7íg‘K(M&$R(.1˜r'J“œÐŠTù€®8£�Vä"£¦AÈ»ÐH÷u} ñ›|Å$½b{Õ–Pšÿ³ý8‰g/]þQAsÙ…(¢ÆÌà#›ªLÊ[ººÄßÿÿPK-!‚мú[Content_Types].xmlPK-!¥Ö§çÀ6 +_rels/.relsPK-!ky–ƒŠtheme/theme/themeManager.xmlPK-!–µ­â–PÑtheme/theme/theme1.xmlPK-! Ñ�Ÿ¶'› theme/theme/_rels/themeManager.xml.relsPK]– C ÿÿÿÿC –©C ð8ð@ñÿÿÿ€€€÷ð’ðð0ð( ð ððB ðS ð¿Ëÿ ?ð;@AGŸ¤"39>ª ¯ E  E 3B E B E zûp>ë�ÿÿÿÿÿÿÿÿÿ´}ŽzÀí³ú‚ÿÿÿÿÿÿÿÿÿ„<„˜þÆ<^„<`„˜þo(.„ª„˜þƪ^„ª`„˜þo(()‚„z„LÿÆz^„z`„Lÿ.€„J „˜þÆJ ^„J `„˜þ.€„ „˜þÆ ^„ `„˜þ.‚„ê„LÿÆê^„ê`„Lÿ.€„º„˜þƺ^„º`„˜þ.€„Š„˜þÆŠ^„Š`„˜þ.‚„Z„LÿÆZ^„Z`„Lÿ. „Є˜þÆÐ^„Ð`„˜þOJQJo(·ð€„ „˜þÆ ^„ `„˜þOJQJ^Jo(o€ „p„˜þÆp^„p`„˜þOJQJo(§ð€ „@ „˜þÆ@ ^„@ `„˜þOJQJo(·ð€„„˜þÆ^„`„˜þOJQJ^Jo(o€ „à„˜þÆà^„à`„˜þOJQJo(§ð€ „°„˜þư^„°`„˜þOJQJo(·ð€„€„˜þÆ€^„€`„˜þOJQJ^Jo(o€ „P„˜þÆP^„P`„˜þOJQJo(§ð´}Žzzûpÿÿÿÿÿÿÿÿÿÿÿÿ         [åXÀ “BkwgH æJ&d° î=gu(,¥v“[!ú)"ƒZ%l.â3üg8…x;[=Q@B|BïCJqKLØyLw}MmOgNPk,QEuW¥^]"2^H_×aƒ;aMVataèEc°Fe%'gQ=gy&jDzj\AlÍ9oø(tftv¥YxH y%z7g|4&}?7}sl…ÞŠ aŠ”=�w� ~•Þ(˜­u˜.œt9 Æa«í¬’j¯ °„+´‹·±M¹7RÃ.È”~ÌN$ÐhÔå-ÚmOÛé|Þ¦5àð$âËmçg;èûSêïdñz9ñÜBõ}%ùR9ýgþC E ÿ@C h@ÿÿUnknownÿÿÿÿÿÿÿÿÿÿÿÿ G�ï*àAxÀ ÿTimes New Roman5�€Symbol3.� ÿ*àCxÀ ÿArial7.�ï { @ŸCalibriY� CG TimesTimes New Roman7�ï K@ŸCambria?=� ÿ*àCxÀ ÿCourier New;�€WingdingsA�ï ë BŸCambria Math"qˆðÐh‚=ùf‚=ùfÔo �Ôo !ð  ´´��20= = 3ƒðüýHP ðÿ$Päÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ° 2!xx ÿÿRobertRobert  þÿà…ŸòùOh«‘+'³Ù0 pxˆ˜ ¨´ Ô à ìøäRobertNormalRobert2Microsoft Office Word@FÃ#@”³b¡mÌ@”³b¡mÌÔo þÿÕÍÕœ.“—+,ù®0è hp|„Œ” œ¤¬´ ¼ Éä=   Title þÿÿÿ !"#þÿÿÿ%&'()*+þÿÿÿ-./0123þÿÿÿýÿÿÿ6þÿÿÿþÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿRoot Entryÿÿÿÿÿÿÿÿ ÀFðó™m¡mÌ8€1Tableÿÿÿÿÿÿÿÿ&WordDocumentÿÿÿÿÿÿÿÿ4SummaryInformation(ÿÿÿÿ$DocumentSummaryInformation8ÿÿÿÿÿÿÿÿÿÿÿÿ,CompObjÿÿÿÿÿÿÿÿÿÿÿÿyÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿ ÿÿÿÿ ÀF'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.8ô9²q